Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001553350-22-000150
Filing Date
2022-02-14
Accepted
2022-02-11 17:48:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A geovax_13ga.htm SC 13G/A 42624
  Complete submission text file 0001553350-22-000150.txt   44502
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Subject) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-56365 | Film No.: 22623165
SIC: 2834 Pharmaceutical Preparations

Mailing Address 161A SHEDDEN ROAD ONE ARTILLARY COURT P.O. BOX 10085 GRAND KAYMAN E9 KY1-1001
Business Address 161A SHEDDEN ROAD ONE ARTILLARY COURT P.O. BOX 10085 GRAND KAYMAN E9 KY1-1001 646-688-5654
L1 Capital Global Opportunities Master Fund, Ltd. (Filed by) CIK: 0001702202 (see all company filings)

EIN.: 981241877 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A